Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoichi Iriguchi

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|June 12, 2026
Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantationYasuyuki Miyake, Shoichi Iriguchi, Ai Kawana-Tachikawa, et al.
Frontiers in Immunology|February 9, 2026
Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantationYasuyuki Miyake, Shoichi Iriguchi, Ai Kawana-Tachikawa, et al.
Cell Stem Cell|June 7, 2024
Human iPSC-derived CD4<sup>+</sup> Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft modelHisashi Yano, Keiko Koga, Takayuki Sato, et al.
Communications Biology|June 8, 2021
The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-1derived iPS cellsTakeshi Ito, Yohei Kawai, Yutaka Yasui, et al.
Molecular Therapy. Nucleic Acids|August 25, 2018
Generation of HIV-Resistant Macrophages from IPSCs by Using Transcriptional Gene Silencing and Promoter-Targeted RNAKei Higaki, Masako Hirao, Ai Kawana-Tachikawa, et al.
Molecular Therapy. Methods & Clinical Development|April 19, 2021
Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human diseaseYoshihiro Iwamoto, Yohei Seki, Kahoru Taya, et al.
Nature Biomedical Engineering|May 18, 2021
Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cellsBo Wang, Shoichi Iriguchi, Masazumi Waseda, et al.
Stem Cell Reports|February 11, 2016
Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem CellsShuichi Kitayama, Rong Zhang, Tian-Yi Liu, et al.
Cancer Science|March 6, 2020
Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cellsTatsuki Ueda, Ayako Kumagai, Shoichi Iriguchi, et al.
Stem Cell Reports|May 29, 2018
Generation of TCR-Expressing Innate Lymphoid-like Helper Cells that Induce Cytotoxic T Cell-Mediated Anti-leukemic Cell ResponseNorihiro Ueda, Yasushi Uemura, Rong Zhang, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|June 12, 2026
Correction: Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantationYasuyuki Miyake, Shoichi Iriguchi, Ai Kawana-Tachikawa, et al.
Frontiers in Immunology|February 9, 2026
Non-human primate preclinical model revealed the feasibility and short-term safety of iPSC-derived innate-like T cells in autologous transplantationYasuyuki Miyake, Shoichi Iriguchi, Ai Kawana-Tachikawa, et al.
Cell Stem Cell|June 7, 2024
Human iPSC-derived CD4<sup>+</sup> Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft modelHisashi Yano, Keiko Koga, Takayuki Sato, et al.
Communications Biology|June 8, 2021
The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-1derived iPS cellsTakeshi Ito, Yohei Kawai, Yutaka Yasui, et al.
Molecular Therapy. Nucleic Acids|August 25, 2018
Generation of HIV-Resistant Macrophages from IPSCs by Using Transcriptional Gene Silencing and Promoter-Targeted RNAKei Higaki, Masako Hirao, Ai Kawana-Tachikawa, et al.
Molecular Therapy. Methods & Clinical Development|April 19, 2021
Generation of macrophages with altered viral sensitivity from genome-edited rhesus macaque iPSCs to model human diseaseYoshihiro Iwamoto, Yohei Seki, Kahoru Taya, et al.
Nature Biomedical Engineering|May 18, 2021
Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cellsBo Wang, Shoichi Iriguchi, Masazumi Waseda, et al.
Stem Cell Reports|February 11, 2016
Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem CellsShuichi Kitayama, Rong Zhang, Tian-Yi Liu, et al.
Cancer Science|March 6, 2020
Non-clinical efficacy, safety and stable clinical cell processing of induced pluripotent stem cell-derived anti-glypican-3 chimeric antigen receptor-expressing natural killer/innate lymphoid cellsTatsuki Ueda, Ayako Kumagai, Shoichi Iriguchi, et al.
Stem Cell Reports|May 29, 2018
Generation of TCR-Expressing Innate Lymphoid-like Helper Cells that Induce Cytotoxic T Cell-Mediated Anti-leukemic Cell ResponseNorihiro Ueda, Yasushi Uemura, Rong Zhang, et al.
Pageof 3